PIEZO1 and neoplasm: As discussed for tumor cases and as already proposed for renal tumors [21,121,149], Piezo1 could also be, at least, a biomarker for discriminating the aggressiveness of cardiac fibrosis and, at most, a beneficial therapeutic target.